Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Pediatrics
Published in: Indian Journal of Pediatrics 6/2011

01-06-2011 | Original Article

Evaluation of Growth, Puberty and Endocrine Dysfunctions in Relation to Iron Overload in Multi Transfused Indian Thalassemia Patients

Authors: Rashid H. Merchant, Amruta Shirodkar, Javed Ahmed

Published in: Indian Journal of Pediatrics | Issue 6/2011

Login to get access

Abstract

Objective

To determine the prevalence of growth abnormality and endocrine dysfunction in a group of multi transfused thalassemic children and to correlate these with their body iron stores.

Methods

This cross sectional study included 35 Thalassemia Major patients, aged 13 to 24 years. Growth and puberty were assessed clinically and the laboratory values of various hormone levels were stratified with their age and sexual maturity.

Results

57.14% patients were short, 60% had not attained puberty, and 87.5% of the girls had primary amenorrhea. 14.29% had low FSH and 2.86% low LH levels. 89.47% of the boys had low free testosterone and 43.75% of the girls had low estradiol levels. While 20% had high TSH levels, 40% had high PTH levels, of which 92.8% had low levels of Vitamin D. Low levels of IGF-1 were noted in 51.43%.

Conclusions

In this study analysis, short stature and hypogonadism were frequent findings. These results support the need for vigilant clinical evaluation of growth and puberty, as well as appropriate hormonal evaluation in poly transfused thalassemic children in order to detect and treat endocrine dysfunction early. The authors also recommend aggressive and adequate chelation from early life so that permanent damage to the endocrine glands can be prevented.
Literature
1.
Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Complications of β-thalassemia major in North America. Blood. 2004;104:34–9.PubMedCrossRef
2.
Aydinok Y, Darcan S, Polat A, et al. Endocrine complications in patients with β-thalassemia major. J Trop Pediatr. 2002;48:50–4.PubMedCrossRef
3.
Lo L, Singer ST. Thalassemia: Current approach to an old disease. Pediatr Clin North Am. 2002;49:1165–91.PubMedCrossRef
4.
Borgna-Pignatti C, De Stefano P, Zonta L, et al. Growth and sexual maturation in thalassemia major. J Pediatr. 1985;106:150–5.PubMedCrossRef
5.
6.
Kattamis C, Liakopoulou T, Kattamis A. Growth and development in children with thalassaemia major. Acta Paediatr Scand Suppl. 1990;366:111–7.PubMedCrossRef
7.
Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab. 1997;10:175–84.PubMedCrossRef
8.
George A, Bhaduri A, Sen S, Choudhry VP. Physical growth parameters in thalassemic children. Indian J Pediatr. 1997;64:861–71.PubMedCrossRef
9.
De Virgiliis S, Cossu P, Toccafondi C, et al. Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients. Am J Pediatr Hematol Oncol. 1983;5:73–7.PubMed
10.
Fargion S, Taddei MT, Gabutti V, et al. Early iron overload in beta-thalassaemia major: when to start chelation therapy? Arch Dis Child. 1982;57:929–33.PubMedCrossRef
11.
Wu KH, Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol. 2003;82:637–40.PubMedCrossRef
12.
Karydis I. Karagiorga-Lagana M, Nounopoulos C, Tolis G. Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in beta-thalassemia major. J Pediatr Endocrinol Metab. 2004;17:17–25.PubMedCrossRef
13.
Low LC, Postel-Vinay MC, Kwan EY, Cheung PT. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment. Clin Endocrinol (Oxf). 1998;48:641–6.CrossRef
14.
Ghosh S, Bandyopadhyay SK, Bandyopadhyay R, Roy D, Maisnam I, Ghosh MK. A study on endocrine dysfunction in thalassaemia. J Indian Med Assoc. 2008;106:655–9.PubMed
15.
Flynn DM, Hoffbrand AV, Politis D. Subcutaneous desferrioxamine: the effect of three years’ treatment on liver, iron, serum ferritin, and comments on echocardiography. Birth Defects Orig Artic Ser. 1982;18:347–53.PubMed
16.
Agarwal MB, Shah S, Vishwanathan C, et al. Thyroid dysfunction in multi-transfused iron loaded thalassemia patients. Indian Pediatr. 1992;29:997–1002.PubMed
17.
Hader A, Bashir N, Hasan Z, Khatib S. Thyroid function in children with beta-thalassemia major in north Jordan. J Trop Pediatr. 1993;39:107–10.
18.
Cavallo L, Licci D, Acquafredda A, et al. Endocrine involvement in children with beta–thalassaemia major. Transverse and longitudinal studies. I. Pituitary–thyroidal axis function and its correlation with serum ferritin levels. Acta Endocrinol (Copenh). 1984;107:49–53.
19.
Filosa A, Di Maio S, Aloj G, Acampora C. Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab. 2006;19:1397–404.PubMedCrossRef
20.
Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab. 2000;13:651–6.PubMedCrossRef
21.
Italian Working Group on Endocrine Complications in Non–Endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol (Oxf). 1995;42:581–6.CrossRef
22.
Chern JP, Lin KH. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Pediatr Hematol Oncol. 2002;24:291–3.PubMedCrossRef
23.
Srivatsa A, Marwaha RK, Muralidharan R. Trehan A. Assessment of Adrenal Endocrine Function in Asian Thalassemics: Indian Pediatrics. 2005;42:31–5.PubMed
24.
Tyagi S, Kabra M, Tandon N, Saxena R, Pati H, Choudhry VP. linico haematological profile of thalassemia Intermedia patients. Int. J Hum Genet. 2003;3:251–8.
25.
Jain M, Sinha RS, Chellani H, Anand NK. Assessment of thyroid functions and its role in body growth in thalassemia major. Indian Pediatr. 1995;32:213–9.PubMed
26.
Agarwal MB. Deferasirox: oral, once daily iron chelator–an expert opinion. Indian J Pediatr. 2010;77:185–91.PubMedCrossRef
27.
28.
Choudhry VP, Naithani R. Current status of iron overload and chelation with deferasirox. Indian J Pediatr. 2007;74:759–64.PubMedCrossRef
Metadata
Title
Evaluation of Growth, Puberty and Endocrine Dysfunctions in Relation to Iron Overload in Multi Transfused Indian Thalassemia Patients
Authors
Rashid H. Merchant
Amruta Shirodkar
Javed Ahmed
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Indian Journal of Pediatrics / Issue 6/2011
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-010-0351-3

Other articles of this Issue 6/2011

Indian Journal of Pediatrics 6/2011 Go to the issue

Symposium on PICU Protocols AIIMS

Management of Common Oncologic Emergencies

Original Article

Status of Iodine Content of Salt in Four Regions of India

Clinical Brief

Celiac Disease with Splenic Calcifications

Clinical Brief

Gorham-Stout Syndrome with Chylothorax in a Six-Year-Old Boy

Scientific Letters to the Editor

Splenic Lesions in Visceral Leishmaniasis

Original Article

Pain Response in Newborns to the Order of Injecting BCG and Hepatitis-B Vaccines: A Randomized Trial